- •
Plantar hyperhidrosis affects the quality of life for patients.
- •
The source of hyperhidrosis should be investigated before initiating treatment.
- •
Various pharmacologic and nonpharmacologic treatments exist, but many offer temporary solutions.
Plantar Hyperhidrosis: An Overview
Section snippets
Key points
Patient evaluation overview
Plantar hyperhidrosis is typically primary hyperhidrosis and idiopathic, but hyperhidrosis is divided into primary and secondary categories.2 Primary hyperhidrosis tends to be an idiopathic increase in sympathetic nervous system activity; secondary usually is caused by either a medication or an underlying disease.2 In the study by Walling2 of 415 patients, 93.3% had primary and the remaining 6.7% had secondary. Primary hyperhidrosis tends to be typically distributed in the axilla, palms, soles,
Pharmacologic treatment options
Treatment of plantar hyperhidrosis has used various strategies. The first line of treatment has been application of an antiperspirant, such as topical aluminum chloride.1 In 2011, Streker and colleagues1 conducted a study on the effectiveness of two different concentrations of aluminum chloride, 12.5% and 30%, and found that both significantly reduced sweat production in plantar hyperhidrosis in 6 weeks. Because both were effective, they recommend using aluminum chloride 12.5%.1 Although skin
Nonpharmacologic treatment options
Laser treatment of hyperhidrosis has been explored for treatment of hyperhidrosis. The miraDry (Miramar Labs, Santa Clara, CA) laser has been tested for treatment of axillary hyperhidrosis, but not plantar hyperhidrosis. It uses microwave energy at 5800 MHz, which is between infrared (CO2 lasers) and radiowaves on the electromagnetic spectrum.24 Using an antenna, the microwave energy penetrates the skin to the eccrine sweat glands, preferentially targeting the skin-adipose junction where most
Summary/Discussion
Plantar hyperhidrosis has a significant impact on the quality of life for patients. It is important to be able to understand and diagnose this condition, and to be familiar with available treatment options. Determining the cause, if possible, for the hyperhidrosis is paramount before initiating other systemic or more invasive procedures. Evaluating the disruption of the patient’s quality of life is useful in determining the treatment plan and understanding the unique needs of the patient with
Acknowledgment
Samantha M. Newstadt, BS for her assistance with this article.
References (27)
Clinical differentiation of primary from secondary hyperhidrosis
J Am Acad Dermatol
(2011)Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients
J Am Acad Dermatol
(2009)- et al.
Recognition, diagnosis, and treatment of primary focal hyperhidrosis
J Am Acad Dermatol
(2004) - et al.
Botulinum neurotoxin treatment of palmar and plantar hyperhidrosis
Dermatol Clin
(2014) - et al.
Iontophoresis for palmar and plantar hyperhidrosis
Dermatol Clin
(2014) - et al.
Hyperhidrosis plantaris: a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminum chloride
J Dtsch Dermatol Ges
(2012) - et al.
Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil
An Bras Dermatol
(2015) - et al.
An epidemiological study of hyperhidrosis
Dermatol Surg
(2007) - et al.
Temperament and character properties of primary focal hyperhidrosis patients
Health Qual Life Outcomes
(2013) - et al.
Primary hyperhidrosis: evidence for autosomal dominant inheritance
Clin Auton Res
(2003)
Analysis of family history of palmoplantar hyperhidrosis in Japan
J Dermatol
Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis
An Bras Dermatol
Quality of life after endoscopic lumbar sympathectomy for primary plantar hyperhidrosis
World J Surg
Cited by (0)
Disclosure: The author has nothing to disclose.